Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity.

Tadagaki K, Tudor D, Gbahou F, Tschische P, Waldhoer M, Bomsel M, Jockers R, Kamal M.

Blood. 2012 May 24;119(21):4908-18. doi: 10.1182/blood-2011-08-372516. Epub 2012 Apr 10.

2.

Heteromerization of human cytomegalovirus encoded chemokine receptors.

Tschische P, Tadagaki K, Kamal M, Jockers R, Waldhoer M.

Biochem Pharmacol. 2011 Sep 15;82(6):610-9. doi: 10.1016/j.bcp.2011.06.009. Epub 2011 Jun 13.

3.

Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry.

Pleskoff O, Tréboute C, Brelot A, Heveker N, Seman M, Alizon M.

Science. 1997 Jun 20;276(5320):1874-8.

5.

Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.

Tu CC, Arnolds KL, O'Connor CM, Spencer JV.

J Virol. 2018 Feb 12;92(5). pii: e01981-17. doi: 10.1128/JVI.01981-17. Print 2018 Mar 1.

6.

The HCMV chemokine receptor US28 is a potential target in vascular disease.

Streblow DN, Orloff SL, Nelson JA.

Curr Drug Targets Infect Disord. 2001 Aug;1(2):151-8. Review.

PMID:
12455411
7.

Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.

Richter R, Casarosa P, Ständker L, Münch J, Springael JY, Nijmeijer S, Forssmann WG, Vischer HF, Vakili J, Detheux M, Parmentier M, Leurs R, Smit MJ.

J Immunol. 2009 Jul 15;183(2):1229-37. doi: 10.4049/jimmunol.0802145. Epub 2009 Jun 24.

8.

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

Scarlatti G, Tresoldi E, Björndal A, Fredriksson R, Colognesi C, Deng HK, Malnati MS, Plebani A, Siccardi AG, Littman DR, Fenyö EM, Lusso P.

Nat Med. 1997 Nov;3(11):1259-65.

PMID:
9359702
9.

Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes.

Fraile-Ramos A, Pelchen-Matthews A, Kledal TN, Browne H, Schwartz TW, Marsh M.

Traffic. 2002 Mar;3(3):218-32.

10.

Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G.

Virology. 1999 Nov 25;264(2):370-84.

11.

Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes.

Casarosa P, Gruijthuijsen YK, Michel D, Beisser PS, Holl J, Fitzsimons CP, Verzijl D, Bruggeman CA, Mertens T, Leurs R, Vink C, Smit MJ.

J Biol Chem. 2003 Dec 12;278(50):50010-23. Epub 2003 Sep 30.

12.
13.

Pharmacological and biochemical characterization of human cytomegalovirus-encoded G protein-coupled receptors.

Maussang D, Vischer HF, Schreiber A, Michel D, Smit MJ.

Methods Enzymol. 2009;460:151-71. doi: 10.1016/S0076-6879(09)05207-0.

PMID:
19446724
14.

Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.

Chelucci C, Casella I, Federico M, Testa U, Macioce G, Pelosi E, Guerriero R, Mariani G, Giampaolo A, Hassan HJ, Peschle C.

Blood. 1999 Sep 1;94(5):1590-600.

15.

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Björndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, Fenyö EM.

J Virol. 1997 Oct;71(10):7478-87.

16.

Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5.

Zhukovsky MA, Lee PH, Ott A, Helms V.

Proteins. 2013 Apr;81(4):555-67. doi: 10.1002/prot.24211. Epub 2012 Dec 24.

PMID:
23161741
17.

gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.

Catani MV, Corasaniti MT, Navarra M, Nisticò G, Finazzi-Agrò A, Melino G.

J Neurochem. 2000 Jun;74(6):2373-9.

18.

Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Mörner A, Björndal A, Albert J, Kewalramani VN, Littman DR, Inoue R, Thorstensson R, Fenyö EM, Björling E.

J Virol. 1999 Mar;73(3):2343-9.

19.

Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.

Boutet A, Salim H, Taoufik Y, Lledo PM, Vincent JD, Delfraissy JF, Tardieu M.

Glia. 2001 May;34(3):165-77.

PMID:
11329179
20.

Supplemental Content

Support Center